HRWR: Predicting Potential Efficacious Drug Combination Based on Hypergraph Random Walk with Restart
Abstract
Some studies have shown that efficacious drug combination can increase the therapeutic effect, and decrease drug toxicity and side-effects. Thus, drug combinations have been widely used in the treatment of complex diseases, especially cancer. However, experiment-based methods are extremely costly in time and money. Computational models can greatly reduce the cost, but most of the models do not use the data of more than two drugs and lose a lot of useful information. Here, we used high-order drug combination information and developed a hypergraph random walk with restart model (HRWR) for efficacious drug combination prediction. As a result, compared with the other methods by leave-one-out cross-validation (LOOCV), the Area Under Receiver Operating Characteristic Curve (AUROC) of the HRWR algorithm were higher than others. Moreover, the case studies of lung cancer, breast cancer, and colorectal cancer showed that HRWR had a powerful ability to predict potential efficacious combinations, which provides new prospects for cancer treatment. The code and dataset of HRWR are freely available at https://github.com/wangqi27/HRWR.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 2
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- RWRDC: Predicting Efficacious Drug Combinations in Cancer Based on Random Walk with Restart
Qi Wang, Guiying Yan·bioRxiv·Sep 13, 2020
- IHRW: An Improved Hypergraph Random Walk Model for Predicting Three-Drug Therapy
Qi Wang, Guiying Yan·bioRxiv·Feb 25, 2021
- DrugCombDB: a comprehensive database of drug combinations toward network medicine and combination therapy
- Network-based estimation of therapeutic efficacy and adverse reaction potential for prioritisation of anti-cancer drug combinations
Arindam Ghosh, Vittorio Fortino·Computational and Structural Biotechnology JournalPeer-reviewed·Dec 7, 2024
- Personalized anti-cancer drug combination prediction by an Integrated Multi-level Network
Fangyoumin Feng, Zhengtao Zhang, … Hong Li·bioRxiv·May 12, 2020
- Multi-task learning predicts drug combination synergy in cells and in the clinic
C. M. Gilvary, J. R. Dry, O. Elemento·bioRxiv·Mar 13, 2019